Unique business models reign
Invacare and ResMed, two of the industry’s few public companies, made the list of most read stories again in 2014, but it was a newcomer, Inogen, that nearly stole the top spot.
Inogen opened for public trading in February of last year and proceeded to wow investors during its subsequent earnings calls with its unique manufacturer-provider business model.
Both Inogen and ResMed say that the worst of competitive bidding is behind the HME industry.
Invacare made the list for its ongoing struggle to lift a consent decree imposed by the U.S. Food and Drug Administration. In 2014, the company also announced a number of changes to its executive leadership.
Taking the top spot was AssuraMed, which bought a competitor of its Edgepark Medical Supply business unit in 2014. Previously, the company bought Invacare Supply Group. Like Inogen, AssuraMed has raised eyebrows with a unique business model that includes both distributor and provider business lines.
Rounding out the top stories is Brightree, which announced a rebrand in 2014 following numerous acquisitions inside and outside the HME industry.